

Add to Cart
Ginsenosides are important active ingredients in ginseng. They belong to the triterpenoid glycoside family and can be divided into protopanaxadiol saponins (PPD-type saponins), protopanaxatriol saponins (PPT-type saponins), and oleanane-type saponins. Over 40 ginsenosides have been isolated from ginseng roots. Ginsenosides exhibit a variety of therapeutic effects, including antioxidant, anti-inflammatory, vasodilator, anti-allergic, and anti-diabetic properties. Some ginsenosides exhibit anti-cancer properties by reducing DNA damage, reducing host susceptibility to mutations, and enhancing immune surveillance and apoptosis. Furthermore, ginsenosides can effectively improve the efficacy of traditional chemotherapy drugs and prevent damage to normal tissues.
1.Anti-tumor Effects
Research has shown that various saponin monomers possess potent
anti-tumor effects, effectively inhibiting the proliferation and
metastasis of various cancer cells.
2.Effects on the Nervous System
Ginsenosides Rb1 and Rg1 exhibit selective neurotrophic and
neuroprotective activities.
3.Protective Effects on the Cardiovascular System
Ginsenosides Rb in ginseng can alleviate myocardial damage caused
by myocardial ischemia and reperfusion. Ginsenoside Rg1 can
significantly reduce the size of post-reperfusion cerebral
infarction and the degree of cerebral edema, alleviate
mitochondrial damage, increase the activity of various enzymes,
including superoxide dismutase (SOD) and glutathione peroxidase
(GSH-Px), reduce malondialdehyde levels, and mitigate cerebral
ischemia-reperfusion injury. Furthermore, ginsenoside Rd can reduce
cholesterol accumulation and prevent atherosclerosis.
4.Immunomodulatory Effects
Ginsenosides can effectively regulate the body's immune system.
In addition, ginsenosides have cardiotonic, myocardial protection, sleep improvement, liver protection, anti-aging, anti-ulcer, anti-inflammatory, anti-depression, and anti-stress effects. They are mainly suitable for coronary heart disease, angina pectoris, bradycardia or tachycardia, ventricular premature contractions, blood pressure disorders, neurasthenia, menopausal syndrome and other diseases.
ITEM | STANDARD | TEST RESULT |
Assay | ≥80% | 83.3% |
Physical & Chemical | ||
Appearance | brown powder | Complies |
Odour | characteristic odour | Complies |
Loss on drying | ≤ 5.0% | 3.6% |
Ash content | ≤ 5.0% | 4.25% |
Particle size | 100% through 80 mesh | 100% |
Heavy Metal | ||
Heavy Metals | < 10ppm | Complies |
Pb | <3ppm | Complies |
As | <1ppm | Complies |
Cd | <2ppm | Complies |
Hg | <0.1ppm | Complies |
Microbiological Test | ||
Total Plate Count | <1000 cfu/g | Complies |
Mold | <100 cfu/g | Complies |